| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |